However, in our study, when we measured the markers of TAMs, including HIF-1α, CCL2, and PECAM1, we found that gemcitabine treatment potently activated the expression of TAM markers, while knockdown of IFI16 reversed the increase in TAMs in the tumor microenvironment (Figure 6F). This evidence concerns the gene CCL2 and neoplasm.